Literature DB >> 2159571

Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts.

D A Palermo-Dilts1, T R Broker, L T Chow.   

Abstract

Human papillomavirus type 1 (HPV-1) causes plantar warts. On the basis of previously mapped mRNAs and sequence homologies of HPV-1 to other papillomaviruses, we designed oligonucleotide primers and employed the polymerase chain reaction to recover HPV-1 cDNAs from plantar warts. Seven spliced RNA species were characterized, including three not previously detected, and the coding potentials of each were deduced. The most abundant viral mRNA encodes an E1i--E4 protein. One new species is predicted to encode the full-length E2 protein, and another can, theoretically, encode the E2-C or E1-M proteins, three products that regulate mRNA transcription and DNA replication. One RNA species originating from a novel HPV promoter in the upstream regulatory region has the potential to encode the minor capsid protein L2. A newly recognized E5a open reading frame (ORF) is contained in all mRNAs that are polyadenylated at the E-region poly(A) site and also in a putative L2 mRNA. Three distinct species, two of which are derived from the upstream regulatory region promoter, have the potential to encode the L1 protein; the third species also contains the entire coding region of the E1i--E4 protein 5' to the L1 ORF. Both the E1i--E4 mRNA and the potentially bicistronic L1 mRNA are derived from a promoter located in the E7 ORF. We uncovered no evidence of alternatively spliced mRNAs that could account for the multiple, abundant E4 proteins in plantar warts, suggesting that posttranslational modification is mainly responsible for the observed protein heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159571      PMCID: PMC249512          DOI: 10.1128/JVI.64.6.3144-3149.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction.

Authors:  M O Rotenberg; L T Chow; T R Broker
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

2.  Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome.

Authors:  R Li; J Knight; G Bream; A Stenlund; M Botchan
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

Review 3.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Identification of the SV40 agnogene product: a DNA binding protein.

Authors:  G Jay; S Nomura; C W Anderson; G Khoury
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  Measurements of the effects that coding for a protein has on a DNA sequence and their use for finding genes.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs.

Authors:  J Choe; P Vaillancourt; A Stenlund; M Botchan
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.

Authors:  M H Stoler; S M Wolinsky; A Whitbeck; T R Broker; L T Chow
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

8.  Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells.

Authors:  C C Baker; J S Noe
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

9.  Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer.

Authors:  M O Rotenberg; C M Chiang; M L Ho; T R Broker; L T Chow
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  32 in total

1.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.

Authors:  Jasmin Fertey; José Hurst; Elke Straub; Astrid Schenker; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells.

Authors:  S Roberts; I Ashmole; L J Gibson; S M Rookes; G J Barton; P H Gallimore
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.

Authors:  Sally Roberts; Michele L Hillman; Gillian L Knight; Phillip H Gallimore
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.

Authors:  S N Stacey; D Jordan; A J Williamson; M Brown; J H Coote; J R Arrand
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.

Authors:  N Yaegashi; S A Jenison; J M Valentine; M Dunn; L B Taichman; D A Baker; D A Galloway
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules.

Authors:  Ingo Ammermann; Markus Bruckner; Frank Matthes; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  The viral E8^E2C repressor limits productive replication of human papillomavirus 16.

Authors:  Elke Straub; Marcel Dreer; Jasmin Fertey; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function.

Authors:  Eve Sankovski; Andres Männik; Jelizaveta Geimanen; Ene Ustav; Mart Ustav
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein--the shortest known NMTS.

Authors:  Eve Sankovski; Kristiina Karro; Mari Sepp; Reet Kurg; Mart Ustav; Aare Abroi
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.